R&D

Research Associate position in the GSBTM-funded project entitled Repurposing of FDA approved therapeutics and its novel formulation to tackle antimicrobial resistance.

Deciphering the contribution of proestrous-estrous transition to seizure susceptibility in drug resistant epilepsy pathologies. Masters degree in Medical Biophysics, Biochemistry, Zoology, Neuroscience, Biomedical Sciences or any other branch of Life Sciences or M.Pharm Pharmacology.

Graduation degree in Life Sciences/ Pharmacy; Unraveling fibrosis-dependent circular RNA and proteomic perturbations in pulmonary disease 

Post Graduate Degree in Life Sciences Biotechnology, Biochemistry, Microbiology, Immunology, etc. with 2 years duration and NET, GATE qualification along with 2 years of research experience after Post-graduation in any of following relevant field

Clinical relevance of mitochondrial signaling in pediatric intraocular malignancy project funded by ANRF Erstwhile SERB-DST for a period of 3 years in the Department of Pediatrics.

First class Post Graduate Degree, including the integrated PG degrees in the area of Pharmacology and Toxicology, Life sciences, Biotechnology, Molecular biology, Immunology, Zoology or equivalent with one year of experience.

Online Applications are invited for various posts as under NATIONAL CANCER GRID - NCG. Candidates who would be called for Interview are required to carry original documents in support of the details furnished in the online application form regarding date of birth, qualifications, experience, etc., failing which such applicants will not be allowed to appear for Interview. 

M.Sc. in any branch of Life Sciences. Prior experience in molecular biology techniques, cell culture assays, expression and purification of proteins, and cellular signaling are required.

Centaur Pharmaceuticals one of the rapidly growing Pharmaceuticals Company in India. Centaur Pharmaceuticals is USFDA and MHRA approved plant is seeking deserving candidates having experience working in Oral Solid Dosage Manufacturing facilities for regulatory market's.